Academic journal publications:
Mungiu-Pippidi, A. and Parvanova, I. (2025), Understanding Integrity: The causes and trends of corruption risk in Europe 41. European Research Center for Anti-Corruption and State-Building Working Paper 66, https://doi.org/10.5281/zenodo.15210511
Parvanova, I. and Lagarde, M. (2024), Framing of sensitive topics in surveys measuring corruption in healthcare. Social Science and Medicine, https://doi.org/10.1016/j.socscimed.2024.117521
Gentilini, A. and Parvanova, I. (2024), Managing experts’ conflicts of interest in the EU Joint Clinical Assessment. BMJ Open, https://bmjopen.bmj.com/content/14/11/e091777
Parvanova, I. (2024). Institutional characteristics and social norms as drivers of petty corruption in healthcare - a multilevel latent class analysis. Governance, https://doi.org/10.1111/gove.12868
Osipenko, L., Potey, P., Perez, B., Angelov, F., Parvanova, I., Ul-Hasan, S. and Mossialos, E. (2024), The Origin of First-in-Class Drugs: Innovation Versus Clinical Benefit, Clinical Pharmacology & Therapeutics, https://doi.org/10.1002/cpt.3110
Parvanova, I., Gentilini, A., Cushing, J., & Naci, H. (2023). Safeguarding NICE from patient groups’ conflicts of interest. BMJ, 381, https://doi.org/10.1136/bmj.p1243
Gentilini, A. and Parvanova, I. (2023) Industry funding of patient organisations in the United Kingdom: a retrospective study of commercial determinants, funding concentration and disease prevalence. BMJ Open, http://dx.doi.org/10.1136/bmjopen-2022-071138
Under review
Informal payments for healthcare - international comparisons (Forthcoming book chapter, with Dr Sara Allin (University of Toronto) and Dr Ilias Kyriopoulos (LSE))
Conflicts of interests and patients organizations - a literature review (with Arianna Gentilini (LSE) and Prof Jillian Kohler (Univeristy of Toronto))
Work in progress
The impact of corruption on social inequalities (with Prof Alina Mungiu-Pippidi (LUISS))
Corruption and citizenship by investment (with Prof Alina Mungiu-Pippidi (LUISS))
Favoritism and corrupt reciprocity - a lab-in-the-field experiment (with Prof Mylene Lagarde (LSE))
Corruption in the supply chain of generic antibiotics - assessing the drivers of counterfeit and falsified drugs (with Transparency International)
A retrospective study of conflicts of interest in the French pharmaceutical industry (with Arianna Gentilini (LSE) and Prof Jillian Kohler (Univeristy of Toronto))
Evidence on the implementation and effectiveness of administrative anti-corruption interventions and their lessons for the healthcare system - a systematic review of evaluations (with Prof Dina Balabanova (LSHTM))
Media coverage and interviews
Doctor bribes: Romania finds rare success among persisting healthcare corruption across Europe, BMJ, https://www.bmj.com/content/384/bmj.q307 [23 February 2024]
Revealed: Drug firms funding UK patient groups that lobby for NHS approval of medicines, The Guardian, https://www.theguardian.com/science/2023/jul/22/revealed-drug-firms-funding-uk-patient-groups-that-lobby-for-nhs-approval-of-medicines [23 July 2023]
Why economics has a problem with women, Open Democracy, https://neweconomics.opendemocracy.net/index.html%3Fp=2561.html, [7 March 2018]
Economics teaching is still neglecting critical thought, The Guardian, https://www.theguardian.com/business/economics-blog/2016/nov/17/economics-teaching-is-still-neglecting-critical-thought, [17 November 2016]
How might Scottish universities change outside the EU?, BBC, https://www.bbc.co.uk/news/uk-scotland-37966846, [14 November 2016]